The Impact of the "Business" of Pain Medicine on Patient Care

Pain Medicine

Volumn 12, Issue 5, 2011, Pages 763-772

  Taylor, Mary Lou ^a  

^a MEDICAL COLLEGE OF WISCONSIN   (United States)

Author keywords

Advertising; Bioethics; Chronic Pain; Ethics; Pain Management; Pain Medicine; Pharmaceuticals

Indexed keywords

ADVERTIZING; ARTICLE; CLINICAL PRACTICE; CONSUMER; DRUG INDUSTRY; DRUG MARKETING; ECONOMIC ASPECT; EVIDENCE BASED MEDICINE; GOVERNMENT; HEALTH CARE DELIVERY; HEALTH CARE SYSTEM; HEALTH INSURANCE; HUMAN; LAW; MEDICAL EDUCATION; MEDICAL SOCIETY; MEDICINE; PAIN; PATIENT CARE; PRACTICE GUIDELINE;

EID: 79955914503     PISSN: 15262375     EISSN: 15264637     Source Type: Journal    
DOI: 10.1111/j.1526-4637.2011.01114.x     Document Type: Article

References (58)

1. Centers for Disease Control and Prevention (CDC). Prevalence of doctor-diagnosed arthritis and arthritis-attributable activity limitation-United States, 2007-2009. MMWR 2006;55:1261-5.
2. Hootman JM, Helmick CG. Projections of US prevalence of arthritis and associated activity limitations. Arthritis Rheum 2006;54:226-9.
3. Martin BI, Deyo RA, Mirza SK, etal. Expenditures and health status among adults with back and neck problems. JAMA 2008;299(6):656-64.
4. Katz JN. Lumbar disc disorders and low-back pain: Socioeconomic factors and consequences. J Bone Joint Surg 2006;88A(suppl 2):21-4.
5. Social Security Online, Actuarial publications (Socialsecurity.gov). Selected data from Social Security's disability program. [Updated 2010 Sep 3]. Available at: (accessed September 2010).
6. Freburger JK, Holmes GM, Agans RP, etal. The rising prevalence of chronic low back pain. Arch Intern Med 2009;169(3):251-8.
7. US Department of Health and Human Services National Center for Health Statistics. Health, United States, 2009: With Special Feature on Medical Technology. Hyattsville, MD: US Government Printing Office; 2010.
8. DFW Airport, TX: SuperMedia LLC [2009-2010]. Available at: (accessed September 2010).
9. Dana J, Loewenstein G. A social science perspective on gifts to physicians from industry. JAMA 2003;290(2):252-5.
10. Fortune 500 top industries: Most profitable. Atlanta, GA: [2009 May 4] Available at: (accessed September 2010).
11. Center for Public Integrity. Pharmaceutical Federal Lobbying Spending Flourishes. Washington, DC: The Center for Public Integrity; c2010 [2007 Apr 4]. Available at: (accessed September 2010).
12. CBS News. Under the influence: 60 Minutes' Steve Kroft reports on drug lobbyists' role in passing bill that keeps drug prices high. New York: CBS Interactive Inc; c2007 [2007 Jul 29]. Available at: (accessed September 2010).
13. Center for Responsive Politics (OpenSecrets.org). Lobbying top industries 2009. Washington, DC: Center for Responsive Politics; c2010. Available at: (accessed September 2010).
14. Wazana A. Physicians and the pharmaceutical industry: Is a gift ever just a gift? JAMA 2000;283(3):373-80.
15. Mirza SK. Accountability of the accused: Facing public perceptions about financial conflicts of interest in spine surgery. Spine J 2004;4:491-4.
16. Pharmaceutical Research and Manufacturers of America (PHRMA.org). Code on interactions with healthcare professionals. Washington, DC: Pharmaceutical Research and Manufacturers of America; c2010 [Revised 2008 Jun]. Available at: (accessed September 2010).
17. Dubois MY. American Academy of Pain Medicine Ethics Council statement on conflicts of interest: Interaction between physicians and industry in pain medicine. Pain Med 2010;11:257-61.
18. Rust S, Fauber J. Drug firms' cash skews doctor classes: Company-funded UW courses often favor medicine, leave out side effects. Milwaukee J Sentinel 2009;March 29:1.
19. Fauber J. Faculty disclose outside payments: Some UW doctors get 6-figure sums from drug, medical firms. Milwaukee J Sentinel 2009;June 20:1.
20. Bekelman JE, Li Y, Gross CP. Scope and impact of financial conflicts of interest in biomedical research. JAMA 2003;289(4):454-65.
21. Shah RV, Albert TJ, Bruegel-Sanchez V, etal. Industry support and correlation to study outcome for papers published in Spine. Spine 2005;30(9):1099-104.
22. Turner EH, Matthews AM, Linardatos E, Tell RA, Rosenthal R. Selective publication of antidepressant trials and its influence on apparent efficacy. N Engl J Med 2008;358(3):252-60.
23. Turk DC. Clinical effectiveness and cost-effectiveness of treatments for patients with chronic pain. Clin J Pain 2002;18:355-65.
24. Gatchel RJ, Okifuji A. Evidence-based scientific data documenting the treatment and cost-effectiveness of comprehensive pain programs for chronic nonmalignant pain. J Pain 2006;7(11):779-93.
25. Carragee EJ, Don AS, Hurwitz EL, etal. 2009 ISSLS Prize Winner: Does discography cause accelerated progression of degeneration changes in the lumbar disc: A ten-year matched cohort study. Spine 2009;34(21):2338-45.
26. Green RM. Direct-to-consumer advertising and pharmaceutical ethics: The case of Vioxx. Hofstra Law Rev 2006;35(2):749-59.
27. The Henry J. Kaiser Family Foundation (Kff.org). Impact of direct-to-consumer advertising on prescription drug spending. Menlo Park, CA: The Henry J. Kaiser Family Foundation; c2010 [2008 Jun]. Available at: (accessed September 2010).
28. Direct-to-consumer advertising: Review and outlook 2010 (abstract). Rockville, MD: MarketResearch.com; c1999-2010 [2010 May 1]. Available at: (accessed July 2010).
29. Mintzes B, Barer ML, Kravitz RL, etal. How does direct-to-consumer advertising (DTCA) affect prescribing? A survey in primary care environments with and without legal DTCA. Can Med Assoc J 2003;169(5):405-12.
30. North American Spine (Northamericanspine.com). The AccuraScope™ Procedure. Dallas, TX: North American Spine; c2010. Available at: (accessed October 2010).
31. Waddell G. A new clinical model for the treatment of low-back pain. Spine 1987;12(7):632-44.
32. Dubois MY, Gallagher RM, Lippe PM. Pain medicine position paper. Pain Med 2009;10(6):972-1000.
33. Deer TR, Krames E, Levy RM, Hassenbusch SJ III, Prager JP. Practice choices and challenges in the current intrathecal environment: An online survey. Pain Med 2009;10(2):304-9.
34. Atli A, Theodore BR, Turk DC, Loeser JD. Intrathecal opioid therapy for chronic nonmalignant pain: A retrospective cohort study with 3-year follow-up. Pain Med 2010;11(7):1010-6.
35. Gift TL, Arnould R, DeBrock L. Is healthy competition healthy? New evidence of the impact of hospital competition. Inquiry 2002;39(1):45-55.
36. Deyo RA, Mirza SK. The case for restraint in spinal surgery: Does quality management have a role to play? Eur Spine J 2009;18(suppl 3):S331-7.
37. Tiwari V, Heese HS. Specialization and competition in healthcare delivery networks. Health Care Manag Sci 2009;12:306-24.
38. Turk DC, Burwinkle TM. Clinical outcomes, cost-effectiveness, and the role of psychology in treatments for chronic pain sufferers. Prof Psychol Res Pr 2005;36(6):602-10.
39. The Trustees of Dartmouth College (Dartmouthatlas.org). Inpatient back surgeries per 1000 Medicare enrollees, 2005. Lebanon, NH: The Trustees of Dartmouth College; c2010. Available at: (accessed October 2010).
40. Deyo RA, Mirza SK, Martin BI, etal. Trends, major medical complications, and charges associated with surgery for lumbar spinal stenosis in older adults. JAMA 2010;303(13):1259-65.
41. Martin BI, Turner JA, Mirza SK, Lee MJ, Comstock BA, Deyo RA. Trends in health care expenditures, utilization, and health status among US adults with spine problems, 1997-2006. Spine 2009;34(19):2077-84.
42. Manchikanti L, Pampati V, Boswell MV, Smith HS, Hirsch JA. Analysis of the growth of epidural injections and costs in the medicare population: A comparative evaluation of 1997, 2002, and 2006 data. Pain Physician 2010;13(3):199-212.
43. Friedly J, Chan L, Deyo R. Increases in lumbrosacral injections in the Medicare population 1994-2001. Spine 2007;32(16):1754-60.
44. Carey TS, Freburger JK, Holmes GM, etal. A long way to go: Practice pattern and evidence in chronic low back pain care. Spine 2009;34(7):718-24.
45. Chou R, Loeser JD, Owens DK, etal. Interventional therapies, surgery, and interdisciplinary rehabilitation for low back pain: An evidence-based clinical practice guideline from the American Pain Society. Spine 2009;34(10):1066-77.
46. Phelan EA, Deyo RA, Cherkin DC, etal. Helping patients decide about back surgery: A randomized trial of an interactive video program. Spine 2001;26(2):206-12.
47. Schatman M. Dramatically disturbed patients in interdisciplinary pain programs. Pract Pain Manag 2004;4(2):24-9.
48. Block AR, Ohnmeiss DD, Guyer RD, Rashbaum RF, Hochschuler SH. The use of presurgical psychological screening to predict the outcome of spine surgery. Spine J 2001;1:274-82.
49. AAPM Council on Ethics. Ethics charter from American Academy of Pain Medicine. Pain Med 2005;6(3):203-12.
50. Chiropractor sued in Marin, 10 other counties for fraud. [Dec 10, 2010]. Available at: (accessed February 2011).
51. Worldwide distributors. [undated]. Available at: (accessed February 2011).
52. Bradshaw DH, Empy C, Davis P, etal. Trends in funding for research on pain: A report on the National Institutes of Health grant awards over the years 2003 to 2007. J Pain 2008;9(12):1077-87.
53. Painmed.org. AAPMedicine applauds the inclusion of pain care in the new healthcare reform. [Mar 25, 2010]. Available at: (accessed February 2011).
54. National Institutes of Health (Report.nih.gov). Estimates of funding for various research, condition and disease categories (RCDC). [Updated Feb 14, 2011]. Available at: (accessed February 2011).
55. Food and Drug Administration (Fda.gov). Analgesic clinical trials innovation, opportunities, and networks (ACTION) initiative. [Updated Nov 1, 2010]. Available at: (accessed February 2011).
56. Turk DC, Swanson KS, Tunks ER. Psychological approaches in the treatment of chronic pain patients-When pills, scalpels and needles are not enough. Can J Psychiatry 2008;53(4):213-23.
57. Gawande A. The hot spotters: Can we lower medical costs by giving the neediest patients better care? The New Yorker 2011:41-51; Jan 24.
58. Weiner BK, Levi BH. The profit motive and spine surgery. Spine 2004;29(22):2588-91.